CN1051177A - 二氮杂二环胺化合物及其制备方法 - Google Patents
二氮杂二环胺化合物及其制备方法 Download PDFInfo
- Publication number
- CN1051177A CN1051177A CN90108666A CN90108666A CN1051177A CN 1051177 A CN1051177 A CN 1051177A CN 90108666 A CN90108666 A CN 90108666A CN 90108666 A CN90108666 A CN 90108666A CN 1051177 A CN1051177 A CN 1051177A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- acid
- compounds
- protecting group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- -1 amine compound Chemical class 0.000 title claims description 29
- 238000002360 preparation method Methods 0.000 title abstract description 49
- 150000001875 compounds Chemical class 0.000 claims abstract description 104
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 25
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 19
- 239000001257 hydrogen Substances 0.000 claims abstract description 19
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- 150000001412 amines Chemical class 0.000 claims abstract description 9
- 125000006239 protecting group Chemical group 0.000 claims description 27
- 239000002253 acid Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 24
- 238000006243 chemical reaction Methods 0.000 claims description 16
- 238000007327 hydrogenolysis reaction Methods 0.000 claims description 16
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 14
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 13
- 238000010511 deprotection reaction Methods 0.000 claims description 12
- 230000002378 acidificating effect Effects 0.000 claims description 11
- 150000001450 anions Chemical class 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- 238000007363 ring formation reaction Methods 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 9
- 125000005843 halogen group Chemical group 0.000 claims description 9
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 8
- 229910052794 bromium Inorganic materials 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 8
- 239000005977 Ethylene Substances 0.000 claims description 7
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 claims description 7
- 238000005804 alkylation reaction Methods 0.000 claims description 6
- 229910021529 ammonia Inorganic materials 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 150000002466 imines Chemical class 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 5
- 230000029936 alkylation Effects 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 5
- 125000001246 bromo group Chemical group Br* 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000002346 iodo group Chemical group I* 0.000 claims description 3
- 238000005698 Diels-Alder reaction Methods 0.000 claims description 2
- 230000002152 alkylating effect Effects 0.000 claims description 2
- 125000004202 aminomethyl group Chemical group [H]N([H])C([H])([H])* 0.000 claims description 2
- 125000004970 halomethyl group Chemical group 0.000 claims description 2
- 125000000623 heterocyclic group Chemical group 0.000 claims description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims description 2
- 150000002483 hydrogen compounds Chemical class 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940125890 compound Ia Drugs 0.000 claims 1
- 239000000543 intermediate Substances 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 10
- 150000007660 quinolones Chemical class 0.000 abstract description 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 27
- 239000011541 reaction mixture Substances 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 25
- 238000005160 1H NMR spectroscopy Methods 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 24
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 24
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 22
- 239000002904 solvent Substances 0.000 description 22
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 21
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 20
- 238000002844 melting Methods 0.000 description 19
- 230000008018 melting Effects 0.000 description 19
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 18
- 238000010992 reflux Methods 0.000 description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 15
- 239000007787 solid Substances 0.000 description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
- 238000000354 decomposition reaction Methods 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 10
- 239000002585 base Substances 0.000 description 10
- 235000019253 formic acid Nutrition 0.000 description 10
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 7
- BLTXQAIMJKGVPV-UHFFFAOYSA-N 1,2,3,4,5,6-hexahydropyrrolo[3,4-c]pyrrole;dihydrobromide Chemical compound Br.Br.C1NCC2=C1CNC2 BLTXQAIMJKGVPV-UHFFFAOYSA-N 0.000 description 6
- GJZKNORRVIUCCH-UHFFFAOYSA-N 1,4-dibromo-2,3-bis(bromomethyl)but-2-ene Chemical group BrCC(CBr)=C(CBr)CBr GJZKNORRVIUCCH-UHFFFAOYSA-N 0.000 description 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 6
- 0 BC*(C)=C(CBr)CI Chemical compound BC*(C)=C(CBr)CI 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical compound CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 description 6
- 102100035593 POU domain, class 2, transcription factor 1 Human genes 0.000 description 5
- 101710084414 POU domain, class 2, transcription factor 1 Proteins 0.000 description 5
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 5
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- USPASZHJABQYSZ-UHFFFAOYSA-N 2-(4-methylphenyl)sulfonyl-1,3,4,5,6,7-hexahydropyrrolo[3,4-c]pyridine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(CNCC2)=C2C1 USPASZHJABQYSZ-UHFFFAOYSA-N 0.000 description 4
- WYHGXYZJLUANMJ-UHFFFAOYSA-N 3,4-bis(bromomethyl)-1-(4-methylphenyl)sulfonyl-2,5-dihydropyrrole Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(CBr)=C(CBr)C1 WYHGXYZJLUANMJ-UHFFFAOYSA-N 0.000 description 4
- 241000192125 Firmicutes Species 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 4
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 4
- 229940072132 quinolone antibacterials Drugs 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 4
- KGLCNBOXQUHILF-UHFFFAOYSA-N 1,2,3,4,5,6-hexahydropyrrolo[3,4-c]pyrrole Chemical compound C1NCC2=C1CNC2 KGLCNBOXQUHILF-UHFFFAOYSA-N 0.000 description 3
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 3
- MOSBJQRMGQQHGY-UHFFFAOYSA-N 2,3,4,5,6,7-hexahydro-1h-pyrrolo[3,4-c]pyridine;dihydrobromide Chemical compound Br.Br.C1CNCC2=C1CNC2 MOSBJQRMGQQHGY-UHFFFAOYSA-N 0.000 description 3
- NLNRRQCTHBQXJB-UHFFFAOYSA-N 2-methyl-1,3,4,5,6,7-hexahydropyrrolo[3,4-c]pyridine;dihydrobromide Chemical compound Br.Br.C1NCCC2=C1CN(C)C2 NLNRRQCTHBQXJB-UHFFFAOYSA-N 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 3
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 125000004391 aryl sulfonyl group Chemical group 0.000 description 3
- 125000004432 carbon atom Chemical group C* 0.000 description 3
- 239000003610 charcoal Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 229910052763 palladium Inorganic materials 0.000 description 3
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 description 3
- 239000002798 polar solvent Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- JHOHWJIKUDBVDP-UHFFFAOYSA-N 1,2-difluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=CC=C2C(=O)C(C(=O)O)=C(F)N(F)C2=C1 JHOHWJIKUDBVDP-UHFFFAOYSA-N 0.000 description 2
- NMASXYCNDJMMFR-UHFFFAOYSA-N 1-cyclopropyl-6,7,8-trifluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C12=C(F)C(F)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 NMASXYCNDJMMFR-UHFFFAOYSA-N 0.000 description 2
- LGAFXTOPHMOXEP-UHFFFAOYSA-N 2,5-bis-(4-methylphenyl)sulfonyl-1,3,4,6-tetrahydropyrrolo[3,4-c]pyrrole Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(CN(C2)S(=O)(=O)C=3C=CC(C)=CC=3)=C2C1 LGAFXTOPHMOXEP-UHFFFAOYSA-N 0.000 description 2
- WGOFRQKKWLZRDA-UHFFFAOYSA-N 2,5-dimethyl-1,3,4,6-tetrahydropyrrolo[3,4-c]pyrrole;dihydrobromide Chemical compound Br.Br.C1N(C)CC2=C1CN(C)C2 WGOFRQKKWLZRDA-UHFFFAOYSA-N 0.000 description 2
- JGXMQVRCAJCSHJ-UHFFFAOYSA-N 2-[4-(bromomethyl)-1-(4-methylphenyl)sulfonyl-2,5-dihydropyrrol-3-yl]acetonitrile Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(CC#N)=C(CBr)C1 JGXMQVRCAJCSHJ-UHFFFAOYSA-N 0.000 description 2
- OUYLPBAISPSRBV-UHFFFAOYSA-N 2-[4-(bromomethyl)-1-(4-methylphenyl)sulfonyl-2,5-dihydropyrrol-3-yl]ethanamine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(CCN)=C(CBr)C1 OUYLPBAISPSRBV-UHFFFAOYSA-N 0.000 description 2
- ILNJBIQQAIIMEY-UHFFFAOYSA-N 4-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1=CC=CC2=C(O)C(C(=O)O)=CN=C21 ILNJBIQQAIIMEY-UHFFFAOYSA-N 0.000 description 2
- MMURJENLPISZNE-UHFFFAOYSA-N 5-benzyl-1,2,3,4,6,7-hexahydropyrrolo[3,4-c]pyridine;hydrobromide Chemical compound Br.C1CC(CNC2)=C2CN1CC1=CC=CC=C1 MMURJENLPISZNE-UHFFFAOYSA-N 0.000 description 2
- BOXYFYGBSAVVIE-UHFFFAOYSA-N 5-methyl-2,3,4,6-tetrahydro-1h-pyrrolo[3,4-c]pyrrole;dihydrobromide Chemical compound Br.Br.C1N(C)CC2=C1CNC2 BOXYFYGBSAVVIE-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OGPPOTXGEXKNNM-UHFFFAOYSA-N Cl.FC=1N(C2=CC=CC=C2C(C1C(=O)O)=O)F Chemical compound Cl.FC=1N(C2=CC=CC=C2C(C1C(=O)O)=O)F OGPPOTXGEXKNNM-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- YKWNUSJLICDQEO-UHFFFAOYSA-N ethoxyethane;propan-2-ol Chemical compound CC(C)O.CCOCC YKWNUSJLICDQEO-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 150000003335 secondary amines Chemical class 0.000 description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QDUGGYAKXPEHDR-UHFFFAOYSA-N 1-cyclopropyl-6,8-difluoro-4-oxo-7-(2,3,4,6-tetrahydro-1h-pyrrolo[3,4-c]pyrrol-5-yl)quinoline-3-carboxylic acid Chemical compound C12=C(F)C(N3CC4=C(CNC4)C3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 QDUGGYAKXPEHDR-UHFFFAOYSA-N 0.000 description 1
- PRGFKWSAKQKRQN-UHFFFAOYSA-N 2,3,4,5,6,7-hexahydro-1h-pyrrolo[3,4-c]pyridine Chemical compound C1CNCC2=C1CNC2 PRGFKWSAKQKRQN-UHFFFAOYSA-N 0.000 description 1
- OZUCUCKQZLWFON-UHFFFAOYSA-N 2,3-bis(bromomethyl)buta-1,3-diene Chemical compound BrCC(=C)C(=C)CBr OZUCUCKQZLWFON-UHFFFAOYSA-N 0.000 description 1
- PNLKVCQVHLKYFZ-UHFFFAOYSA-N 2,5-dimethyl-3,4,6,7-tetrahydro-1h-pyrrolo[3,4-c]pyridine;dihydrobromide Chemical compound Br.Br.C1N(C)CCC2=C1CN(C)C2 PNLKVCQVHLKYFZ-UHFFFAOYSA-N 0.000 description 1
- KOALCPAXCCKZBA-UHFFFAOYSA-N 2-methyl-1,3,4,5,6,7-hexahydropyrrolo[3,4-c]pyridine;dihydrochloride Chemical compound Cl.Cl.C1NCCC2=C1CN(C)C2 KOALCPAXCCKZBA-UHFFFAOYSA-N 0.000 description 1
- CDKLGIKXEOZRFG-UHFFFAOYSA-N 2-methyl-5-(4-methylphenyl)sulfonyl-1,3,4,6-tetrahydropyrrolo[3,4-c]pyrrole Chemical compound C1N(C)CC(C2)=C1CN2S(=O)(=O)C1=CC=C(C)C=C1 CDKLGIKXEOZRFG-UHFFFAOYSA-N 0.000 description 1
- 150000004066 3-pyrrolines Chemical class 0.000 description 1
- CQPUZLMNORVQPG-UHFFFAOYSA-N 5-amino-1-cyclopropyl-6,7,8-trifluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)C=2C(N)=C(F)C(F)=C(F)C=2N1C1CC1 CQPUZLMNORVQPG-UHFFFAOYSA-N 0.000 description 1
- PNZAQLRQCZTQIH-UHFFFAOYSA-N 5-benzyl-1,2,3,4,6,7-hexahydropyrrolo[3,4-c]pyridine;dihydrobromide Chemical compound Br.Br.C1CC(CNC2)=C2CN1CC1=CC=CC=C1 PNZAQLRQCZTQIH-UHFFFAOYSA-N 0.000 description 1
- BKCNVICHZVKDSS-UHFFFAOYSA-N 5-benzyl-2-(4-methylphenyl)sulfonyl-3,4,6,7-tetrahydro-1H-pyrrolo[3,4-c]pyridine Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1CC(CN(CC=2C=CC=CC=2)CC2)=C2C1 BKCNVICHZVKDSS-UHFFFAOYSA-N 0.000 description 1
- BYUFDIQIPWAUND-UHFFFAOYSA-N 5-benzyl-2-methyl-3,4,6,7-tetrahydro-1h-pyrrolo[3,4-c]pyridine;dihydrobromide Chemical compound Br.Br.C1N(C)CC(CC2)=C1CN2CC1=CC=CC=C1 BYUFDIQIPWAUND-UHFFFAOYSA-N 0.000 description 1
- PATXLKRUTNOVTN-UHFFFAOYSA-N 5-ethyl-2,3,4,6-tetrahydro-1h-pyrrolo[3,4-c]pyrrole;dihydrobromide Chemical compound Br.Br.C1N(CC)CC2=C1CNC2 PATXLKRUTNOVTN-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Natural products CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- FGFZZIDFCKEDSH-UHFFFAOYSA-N C(C)OC(NCNC(O)=O)=O Chemical compound C(C)OC(NCNC(O)=O)=O FGFZZIDFCKEDSH-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- NVKWWNNJFKZNJO-YFKPBYRVSA-N Ofloxacin impurity a Chemical compound N1([C@@H](C)CO2)C=C(C(O)=O)C(=O)C3=C1C2=C(F)C(F)=C3 NVKWWNNJFKZNJO-YFKPBYRVSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- SXDBWCPKPHAZSM-UHFFFAOYSA-N bromic acid Chemical compound OBr(=O)=O SXDBWCPKPHAZSM-UHFFFAOYSA-N 0.000 description 1
- FJFOVISFRWPXDB-UHFFFAOYSA-N carbamoyloxymethyl carbamate Chemical compound NC(=O)OCOC(N)=O FJFOVISFRWPXDB-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002451 electron ionisation mass spectrometry Methods 0.000 description 1
- IGLOYLMJLRCIMZ-UHFFFAOYSA-N ethyl 2-methyl-3,4,6,7-tetrahydro-1h-pyrrolo[3,4-c]pyridine-5-carboxylate Chemical compound C1N(C(=O)OCC)CCC2=C1CN(C)C2 IGLOYLMJLRCIMZ-UHFFFAOYSA-N 0.000 description 1
- HAHFYBHZZWNMHT-UHFFFAOYSA-N ethyl 4,5-bis(bromomethyl)-3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound CCOC(=O)N1CCC(CBr)=C(CBr)C1 HAHFYBHZZWNMHT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000001188 haloalkyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- HVTICUPFWKNHNG-UHFFFAOYSA-N iodoethane Chemical compound CCI HVTICUPFWKNHNG-UHFFFAOYSA-N 0.000 description 1
- 150000003951 lactams Chemical class 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 229960000210 nalidixic acid Drugs 0.000 description 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003797 solvolysis reaction Methods 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR89-15204 | 1989-10-23 | ||
| KR1019890015204A KR910009331B1 (ko) | 1989-10-23 | 1989-10-23 | 디아자비시클로아민 화합물과 그의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1051177A true CN1051177A (zh) | 1991-05-08 |
Family
ID=19290921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN90108666A Pending CN1051177A (zh) | 1989-10-23 | 1990-10-22 | 二氮杂二环胺化合物及其制备方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5089621A (enExample) |
| EP (1) | EP0424852A1 (enExample) |
| JP (1) | JPH03193779A (enExample) |
| KR (1) | KR910009331B1 (enExample) |
| CN (1) | CN1051177A (enExample) |
| CA (1) | CA2028205A1 (enExample) |
| FI (1) | FI905173A7 (enExample) |
| HU (1) | HUT56366A (enExample) |
| IL (1) | IL96090A0 (enExample) |
| IN (1) | IN171604B (enExample) |
| YU (1) | YU198190A (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166060A (zh) * | 2018-09-19 | 2021-07-23 | 福马治疗股份有限公司 | 用丙酮酸激酶激活化合物治疗镰状细胞病 |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR940001770B1 (ko) * | 1991-10-15 | 1994-03-05 | 재단법인 한국화학연구소 | 불포화 아자비시클로아민 화합물과 그의 제조방법 |
| DE4339134A1 (de) * | 1993-11-16 | 1995-05-18 | Bayer Ag | 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate |
| US5457121A (en) * | 1994-09-02 | 1995-10-10 | Eli Lilly And Company | Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake |
| WO2016046837A1 (en) | 2014-09-22 | 2016-03-31 | Cadila Healthcare Limited | An improved process for preparation of pyrrolo[3,4- c] pyrrole compounds and intermediates thereof |
| DK3448859T3 (da) | 2017-03-20 | 2019-09-23 | Forma Therapeutics Inc | Pyrrolopyrrolsammensætninger som pyruvatkinase- (pkr) aktivatorer |
| JP7450610B2 (ja) | 2018-09-19 | 2024-03-15 | ノヴォ・ノルディスク・ヘルス・ケア・アーゲー | ピルビン酸キナーゼｒの活性化 |
| MX2022003254A (es) | 2019-09-19 | 2022-04-18 | Forma Therapeutics Inc | Composiciones activadoras de piruvato cinasa r (pkr). |
| US12128035B2 (en) | 2021-03-19 | 2024-10-29 | Novo Nordisk Health Care Ag | Activating pyruvate kinase R |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE55898B1 (en) * | 1982-09-09 | 1991-02-14 | Warner Lambert Co | Antibacterial agents |
| JP2844079B2 (ja) * | 1988-05-23 | 1999-01-06 | 塩野義製薬株式会社 | ピリドンカルボン酸系抗菌剤 |
-
1989
- 1989-10-23 KR KR1019890015204A patent/KR910009331B1/ko not_active Expired
-
1990
- 1990-09-19 IN IN745/MAS/90A patent/IN171604B/en unknown
- 1990-10-19 FI FI905173A patent/FI905173A7/fi not_active Application Discontinuation
- 1990-10-19 US US07/598,888 patent/US5089621A/en not_active Expired - Fee Related
- 1990-10-20 HU HU906520A patent/HUT56366A/hu unknown
- 1990-10-22 YU YU198190A patent/YU198190A/sh unknown
- 1990-10-22 CN CN90108666A patent/CN1051177A/zh active Pending
- 1990-10-22 CA CA002028205A patent/CA2028205A1/en not_active Abandoned
- 1990-10-22 EP EP90120242A patent/EP0424852A1/en not_active Withdrawn
- 1990-10-22 JP JP2282069A patent/JPH03193779A/ja active Pending
- 1990-10-23 IL IL96090A patent/IL96090A0/xx unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113166060A (zh) * | 2018-09-19 | 2021-07-23 | 福马治疗股份有限公司 | 用丙酮酸激酶激活化合物治疗镰状细胞病 |
| CN113166060B (zh) * | 2018-09-19 | 2024-01-09 | 诺沃挪第克健康护理股份公司 | 用丙酮酸激酶激活化合物治疗镰状细胞病 |
Also Published As
| Publication number | Publication date |
|---|---|
| FI905173A7 (fi) | 1991-04-24 |
| KR910007932A (ko) | 1991-05-30 |
| US5089621A (en) | 1992-02-18 |
| KR910009331B1 (ko) | 1991-11-11 |
| EP0424852A1 (en) | 1991-05-02 |
| HU906520D0 (en) | 1991-04-29 |
| IL96090A0 (en) | 1991-07-18 |
| FI905173A0 (fi) | 1990-10-19 |
| CA2028205A1 (en) | 1991-04-24 |
| YU198190A (sh) | 1993-05-28 |
| HUT56366A (en) | 1991-08-28 |
| JPH03193779A (ja) | 1991-08-23 |
| IN171604B (enExample) | 1992-11-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1138774C (zh) | 取代的6,6-杂-双环衍生物 | |
| CN1014789B (zh) | 取代的桥式二氮二环烷基喹诺酮羧酸的制备方法 | |
| CN1446218A (zh) | 苯并咪唑衍生物,它们的制备方法以及它们的治疗应用 | |
| CN1051176A (zh) | 喹诺酮化合物及其制备方法 | |
| CN1118598A (zh) | 吡咯并吡啶衍生物 | |
| CN1608050A (zh) | 哌嗪衍生物 | |
| CN1199974C (zh) | 作为甘氨酸转运抑制剂的螺(2h－1－苯并吡喃－2,4’－哌啶)衍生物 | |
| CN1191248C (zh) | 作为多巴胺d 受体亚型配体的1－(2－萘基)和1－(2－氮杂萘基)－4－(1－苯基甲基)哌嗪 | |
| CN1118467C (zh) | 1,3,8－三氮杂螺[4,5]癸－4－酮衍生物 | |
| CN1251586A (zh) | 新颖嘧啶衍生物及其制法 | |
| CN1620290A (zh) | 作为5－羟色胺－6配体的吲哚基烷基胺衍生物 | |
| CN1250544C (zh) | 吡啶并芳基苯基噁唑烷酮抗菌剂和相关组合物及方法 | |
| CN1771234A (zh) | 吡咯并三嗪激酶抑制剂的制备方法 | |
| CN1051177A (zh) | 二氮杂二环胺化合物及其制备方法 | |
| CN1247590C (zh) | 2,3－二氢－1,4－二氧芑并[2,3－f]喹啉衍生物的合成方法 | |
| CN1434819A (zh) | 4－苯基－1－哌嗪基、－哌啶基和－四氢吡啶基衍生物 | |
| CN1052864A (zh) | 喹诺酮化合物及其制备方法 | |
| CN1232508C (zh) | 制取喹诺酮和二氮杂萘的环化方法步骤 | |
| CN1267434C (zh) | 抗抑郁的(SSSRI)7,8－二氢－3H－6,9－二氧杂－1,3－二氮杂环戊二烯并[a]萘的氮杂环基甲基衍生物 | |
| CN1256337C (zh) | 抗抑郁的7,8－二氢－1,6,9－三氧杂－3－氮杂－环戊二烯并[a]萘的氮杂环基甲基衍生物 | |
| CN1656101A (zh) | 喜树碱20位酯 | |
| CN1159312C (zh) | 新型嘧啶衍生物及其制备方法 | |
| CN1503801A (zh) | 抗抑郁的2,3－二氢－1,4－二噁英并[2,3－f]喹喔啉的氮杂环基甲基衍生物 | |
| CN1141773A (zh) | 含6-氧代-氮杂䓬吲哚的药物的制备方法 | |
| CN1688307A (zh) | 4－氨基哌啶衍生物,它们的制备方法和它们作为药物的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C01 | Deemed withdrawal of patent application (patent law 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |